Cargando…
High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
BACKGROUND: Recent studies using stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) have reported high tumor response and local control. However, the optimal SBRT dose remains unknown, and it is still not clear whether a dose response relationship for local control (LC) and ove...
Autores principales: | Jang, Won Il, Kim, Mi-Sook, Bae, Sun Hyun, Cho, Chul Koo, Yoo, Hyung Jun, Seo, Young Seok, Kang, Jin-Kyu, Kim, So Young, Lee, Dong Han, Han, Chul Ju, Kim, Jin, Park, Su Cheol, Kim, Sang Bum, Cho, Eung-Ho, Kim, Young Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231524/ https://www.ncbi.nlm.nih.gov/pubmed/24160944 http://dx.doi.org/10.1186/1748-717X-8-250 |
Ejemplares similares
-
Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016) -
Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
por: Jung, Da Hoon, et al.
Publicado: (2014) -
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018) -
Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
por: Bae, Sun Hyun, et al.
Publicado: (2013) -
Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions
por: Bae, Sun Hyun, et al.
Publicado: (2015)